20/02/2024Memery Crystal Promotes Three Real Estate Lawyers
Memery Crystal, the international multidisciplinary London-based law firm, today announces the promotion of three real… Read more
21/06/2019
Nick Davis, CEO of leading cannabis sector law firm, Memery Crystal, will be chairing a panel discussion at the inaugural Institutional Capital & Cannabis Conference Europe (IC3 Europe) in London on June 26.
Nick will be chairing the session entitled ‘The Path to Public Markets’, featuring Perry Antelman, CEO of Abacus; Alex Brooks the Senior Analyst at Canaccord Genuity; David Elsley CEO of Cardiol Therapeutics; Daryyl Jones CEO of Isracann BioSciences and Roby Zomer the Executive Director and CTO of MGC Pharmaceuticals. The discussion will explore the journey of public companies in North America on their route to listing.
IC3 is being hosted by the US Information Management Network (IMN) and Prohibition Partners, a leading source of independent data, intelligence and strategy for the cannabis industry. The event will explore the European Cannabis market and discuss the rapid growth forecast over the coming years, and is part of European Cannabis Week 2019.
Nick Davis, “I am looking forward to being a part of IC3 and European Cannabis Week 2019. The cannabis market in Europe is on the eve of rapid growth, and I am excited that Memery Crystal is leading UK law firm at the forefront of this emerging market”.
Find out more about what is happening at IC3 here.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Memery Crystal, the international multidisciplinary London-based law firm, today announces the promotion of three real… Read more
Memery Crystal Real Estate Disputes Partner, Liam Bell, recently acted for Matthew Blake Jacobs on… Read more
Memery Crystal has advised Investment Evolution Credit plc, a global leader in consumer credit, on… Read more